Cargando…
The Intestinal Microbiota in Metabolic Disease
Gut bacteria exert beneficial and harmful effects in metabolic diseases as deduced from the comparison of germfree and conventional mice and from fecal transplantation studies. Compositional microbial changes in diseased subjects have been linked to adiposity, type 2 diabetes and dyslipidemia. Promo...
Autores principales: | Woting, Anni, Blaut, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848671/ https://www.ncbi.nlm.nih.gov/pubmed/27058556 http://dx.doi.org/10.3390/nu8040202 |
Ejemplares similares
-
Small Intestinal Permeability and Gut-Transit Time Determined with Low and High Molecular Weight Fluorescein Isothiocyanate-Dextrans in C3H Mice
por: Woting, Anni, et al.
Publicado: (2018) -
Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals
por: Benedict, Christian, et al.
Publicado: (2016) -
Clostridium ramosum Promotes High-Fat Diet-Induced Obesity in Gnotobiotic Mouse Models
por: Woting, Anni, et al.
Publicado: (2014) -
Alleviation of high fat diet‐induced obesity by oligofructose in gnotobiotic mice is independent of presence of Bifidobacterium longum
por: Woting, Anni, et al.
Publicado: (2015) -
Clostridium ramosum regulates enterochromaffin cell development and serotonin release
por: Mandić, Ana D., et al.
Publicado: (2019)